Use fluoride: A fluoride toothpaste and rinse can help protect against cavities and enamel erosion
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
Next-generation agents include CagriSema (semaglutide + cagrilintide, NDA filed December 2025, showing 22.7% weight loss), retatrutide (triple GIP/GLP-1/glucagon agonist, 28.7% weight loss in Phase 3), and orforglipron (oral non-peptide GLP-1, submitted to FDA)
Use this tool NOTE: This calculator is provided for educational purposes only and is intended to help patients understand unit conversions on a U-100 insulin syringe
The role of glucagon-like peptide 1 receptor agonists in alcohol use disorder